The global fiducial markers market is expected to grow in the upcoming years due to rise in prevalence of cancer such as lung cancer, breast cancer and prostate cancer. Rise in the usage of radiotherapy in treatment of cancer is expected to boost the growth of the fiducial markers market.
Fiducial marker is a device used in the radiotherapy treatment to mark the area for the surgery and to give accurate radiation dosage. The fiducial marker can mark the exact position of tumor and assist the doctor to give exact radiation dosage to the patient without harming the tissue. There are various types of fiducial markers available, which include polymer-based marker, metal-based marker among others. The fiducial marker technology can also provide 3D view of fiducials and give report for the exact diagnosis for the treatment.
COVID-19 scenario analysis:
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future. Considering these factors, COVID -19 is expected to have significant impact on Fiducial Markers Market.
Top Impacting factors:
- Factors such as increase in the adoption of radiotherapy treatment and devices by the oncologists is expected to drive the fiducial markers market growth.
- Rising demand for Image Guidance Radiation Therapy (IGRT) and Stereotactic Body Radiation therapy (SBRT) treatments can boost the fiducial markers market growth during the forecast period.
- Increase in prevalence of cancer worldwide is expected to boost the global fiducial markers market. Rise in awareness about fiducial markers due to exact diagnosis of cancer will enhance the fiducial markers market growth.
- Restrain factors like complications associated with implantation of products and post- procedure side effects can lower the adoption of fiducial markers in future. High costs associated with fiducial markers and lack of skilled professionals can hinder the growth of fiducial markers market during the forecast period.
New Product Launch / News:
• In 2019,IBA (Ion Beam Applications S.A., EURONEXT), one of the world’s leading provider of solutions for the diagnosis and treatment of cancer, announced that it has sold RadioMed Corporation, IBA’s VISICOIL fiducial markers business, to IZI Medical Products LLC.
• In 2019, Stratpharma AG (Switzerland) expanded its agreement with CIVCO (U.S.) to distribute CIVCO’s radiotherapy solutions globally.
Key benefits of the report:
- This study presents the analytical depiction of the fiducial markers market along with the current trends and future estimations to determine the investments.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the fiducial markers market share.
- The current market is quantitatively analyzed to highlight thefiducial markers market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed fiducial markers market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in thefiducial markers market report:
- Which are the leading market players active in fiducial markers market?
- What the current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
- What Segments and region will drive the market growth & why?
- What are the growth opportunities related to the adoption of Fiducial Markers across the world in the future?
Fiducial Markers Market Report Highlights
| Aspects | Details |
 By Product |
|
 By Modality |
|
 By Cancer type |
|
 By End User |
|
 By Region |
|
 Key Market Players | Boston Scientific Corporation, Medtech, Best Medical International, Medtronic, Naslund Medical AB, Nanovi A/S., Eckert and Ziegler, CIVCO Radiotherapy, IZI Medical Products |
Loading Table Of Content...
